Pamela P. Palmer
2023
In 2023, Pamela P. Palmer earned a total compensation of $814.3K as Chief Medical Officer at AcelRx Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $196,946 |
|---|---|
| Option Awards | $51,092 |
| Salary | $542,252 |
| Stock Awards | $10,780 |
| Other | $13,200 |
| Total | $814,270 |
Palmer received $542.3K in salary, accounting for 67% of the total pay in 2023.
Palmer also received $196.9K in non-equity incentive plan, $51.1K in option awards, $10.8K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Pamela P. Palmer's compensation ranked 1,442nd out of 3,006 executives tracked by ExecPay. In other words, Palmer earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,442 out of 3,006 | 52nd |
Division Manufacturing | 855 out of 1,650 | 48th |
Major group Chemicals And Allied Products | 559 out of 918 | 39th |
Industry group Drugs | 545 out of 881 | 38th |
Industry Pharmaceutical Preparations | 383 out of 637 | 40th |
Source: SEC filing on April 29, 2024.
Palmer's colleagues
We found two more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2023.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019